Drug shortages hit US oncologists hard
نویسندگان
چکیده
منابع مشابه
Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
AIM To evaluate personnel involved in scarce drug prioritization and distribution and the criteria used to inform drug distribution during times of shortage among pediatric hematologists/oncologists. METHODS Using the American Society of Pediatric Hematology/Oncology (ASPHO) membership list, a 20 question survey of pediatric hematologists/oncologists was conducted via email to evaluate person...
متن کاملDrug shortages: causes and cautions.
Drug shortages have increasingly been a problem for pharmacists and clinicians over the past decade. Clinicians need to be aware of the various causes of drug shortages and the issues that may arise as a result, particularly as they relate to medication safety. Numerous resources and strategies are available to mitigate the effects of drug shortages, and clinicians should work with their health...
متن کاملBurnout and career satisfaction among US oncologists.
PURPOSE To evaluate the personal and professional characteristics associated with career satisfaction and burnout among US oncologists. METHODS Between October 2012 and March 2013, the American Society of Clinical Oncology conducted a survey of US oncologists evaluating burnout and career satisfaction. The survey sample included equal numbers of men and women and represented all career stages...
متن کاملOncology Drug Shortages in America
J Adv Pract Oncol 2012;3:96–102 T he issue of drug shortages is only one of the many crucial concerns facing oncology advanced practitioners (APs) in the United States today. However, it may be the most critical issue affecting shortand long-term patient outcomes. Shortterm outcomes may be affected by treatment delays, treatment with less effective alternatives, and increased toxicity. Long-ter...
متن کاملDrug shortages derail CCGs' budgets.
Financial plans of clinical commissioning groups are being derailed by emergency hikes in prices of generic drugs, which have led to soaring costs, The BMJ has learnt. Last month The BMJ reported that ongoing shortages of generic drugs cost the NHS £38m in November 2017, as the government agreed more emergency price increases to boost stocks. An examination of board papers by The BMJ has found ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Generics and Biosimilars Initiative Journal
سال: 2014
ISSN: 2033-6403,2033-6772
DOI: 10.5639/gabij.2014.0301.002